Literature DB >> 2858976

Beta-adrenoreceptors in rat brown adipose tissue: proportions of beta 1- and beta 2-subtypes.

N J Rothwell, M J Stock, D K Sudera.   

Abstract

Binding of (-)-[3H]dihydroalprenolol [( 3H]DHA) to isolated brown adipose tissue (BAT) microsomal membranes was used to estimate beta-adrenoreceptor density, and this was found to be saturable, reversible, and stereospecific. Scatchard analysis indicated a single class of binding sites of equilibrium dissociation constant 2.2 nM, with a maximum number of binding sites of 160-170 fmol/mg protein. These values were unaffected by the age or sex of the animals, and similar Kd values were obtained for binding to heart and lung membranes. The kinetically derived Kd from forward and reverse reactions was 1.4 nM for BAT. Hofstee analysis of displacement of [3H]DHA produced linear plots for propranolol but curvilinear plots for atenolol and ICI 118,551. Atenolol showed 50-fold selectivity for beta 1-receptors and ICI 118,551 50-fold selectivity for beta 2-receptors in heart, lung, and BAT membranes. These plots indicated beta 1:beta 2-receptor ratios of 59:41 for BAT and heart and 25:75 for lung. It is possible that both beta-adrenoreceptor subtypes in BAT may be involved in the activation of thermogenesis in the tissue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858976     DOI: 10.1152/ajpendo.1985.248.4.E397

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  Adrenoceptors in white, brown, and brite adipocytes.

Authors:  Bronwyn A Evans; Jon Merlin; Tore Bengtsson; Dana S Hutchinson
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

2.  The beta-adrenergic radioligand [3H]CGP-12177, generally classified as an antagonist, is a thermogenic agonist in brown adipose tissue.

Authors:  N Mohell; A Dicker
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

Review 3.  Multiple actions of beta-adrenergic agonists on skeletal muscle and adipose tissue.

Authors:  Y T Yang; M A McElligott
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

4.  Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes.

Authors:  M N Sillence; N G Moore; G G Pegg; D B Lindsay
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

5.  Changes in tissue blood flow and beta-receptor density of skeletal muscle in rats treated with the beta2-adrenoceptor agonist clenbuterol.

Authors:  N J Rothwell; M J Stock; D K Sudera
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

6.  Differential adrenergic regulation of the gene expression of the beta-adrenoceptor subtypes beta1, beta2 and beta3 in brown adipocytes.

Authors:  T Bengtsson; B Cannon; J Nedergaard
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

7.  Changes in beta 1- and beta 2-adrenergic receptor mRNA levels in brown adipose tissue and heart of hypothyroid rats.

Authors:  J P Revelli; R Pescini; P Muzzin; J Seydoux; M G Fitzgerald; C M Fraser; J P Giacobino
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

8.  Respective degree of expression of beta 1-, beta 2- and beta 3-adrenoceptors in human brown and white adipose tissues.

Authors:  C Deng; A Paoloni-Giacobino; F Kuehne; O Boss; J P Revelli; M Moinat; M A Cawthorne; P Muzzin; J P Giacobino
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

9.  Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat.

Authors:  F D'Allaire; C Atgié; P Mauriège; P M Simard; L J Bukowiecki
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

10.  Fetal sheep temperatures in utero during cooling and application of triiodothyronine, norepinephrine, propranolol and suxamethonium.

Authors:  H J Schröder; B Hüneke; A Klug; H Stegner; M Carstensen; H P Leichtweiss
Journal:  Pflugers Arch       Date:  1987-11       Impact factor: 3.657

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.